Both 1MT isomers lead to increased gDE7-mediated antitumor protection in WT mice, but only the combination of gDE7 with IDO inhibitors in the absence of IL-6 afforded more efficient tumor cell eradication. The gene discussed is IDO1; the disease is neoplasm.